Autopsy report · NCT01357148

A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Completion of MK-0431A-235 was rendered unnecessary, as the local oversight authority accepted in its stead the results of another study \[MK-0431-234\].”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 years 2 months after it had already started.
Ran for about 1 year 2 months before it stopped.
143 participants enrolled.
Results were posted on the registry 1 year 10 months after it ended.

Vital statistics

Status: Terminated
Sponsor: Merck Sharp & Dohme LLC
Sponsor type: Industry
Conditions: Diabetes Mellitus, Type 2
Interventions: Sitagliptin Phosphate/Metformin HCl (JANUMET®)
Participants: 143

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.